Login

Interactive Brokers Chairman discusses the company's Q2 earnings beat. 00:10:00

Share On Facebook Share On Twitter

Thomas Peterffy, founder and chairman of Interactive Brokers

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unlock business potential with CMG Cloud, offering scalable solutions, latest software releases, and secure global access to enhance project delivery and productivity.|Pramod Jain is the CEO of Computer Modelling Group
00:10:00
Medicare Isn’t Free: Understanding Costs, Part B and Part D Premiums, and IRMAA | Dana Anspach, CEO , Sensible Money, LLC.
00:10:00
Stock Market Volatility and Property Company Impact | Sven-Olof Johansson, CEO, FastPartner AB FPAR.
00:10:00
Israel Englander, founder of Millennium Management, is known for his expertise in quantitative trading and risk management.
00:10:00
Focused on control investments in high quality, middle market companies|Caroline Adams,Vp,Tailwind Management LP
00:00:00
Japara Healthcare (JHC): Andrew Sudholz, Chief Executive Officer & Executive Director
00:10:00
Invests in AI first technology and life science companies as early as possible and enjoy iterating through product|Nathan Benaich,General Partner,Air Street Capital
00:10:00
Kiliaro Group AB CEO Elie Komo on the Acquisition of Sosyopix | Elie Komo, CEO, Kiliaro Group AB.
00:10:00
Paul Erik's Fraser Discusses PolarX's High-Grade Copper-Gold Project in Alaska
00:10:00
Wiser Welcomes Matthews Barnett, CFP, ChFC, CLU
00:10:00
Technology's Impact on the Future: Insights from Asia's Leading Minds at the Forbes Global CEO Conference
00:10:00
Credent: Committed to Transparency and the American Dream of Financial Freedom"

© 2017 - Neuhu+